Can a shingles shot protect transplant patients? new study investigates

NCT ID NCT06262776

First seen Apr 29, 2026 · Last updated Apr 29, 2026

Summary

This study looks at how well the shingles vaccine works in transplant patients who take different medicines to suppress their immune system, compared to their healthy housemates. Researchers will measure immune responses over one year after two doses of the SHINGRIX vaccine. The goal is to understand if the vaccine works differently depending on the medications and overall health status.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Royal Adelaide Hospital

    RECRUITING

    Adelaide, South Australia, 5000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.